View in EDS

Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction?

Saved in:
Bibliographic Details
Title: Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction?
Authors: Lineham J; Department of Cardiology, Alfred Hospital, 55 Commercial Rd, Melbourne 3004, Australia.; Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne 3004, Australia., Dagan M; Department of Cardiology, Alfred Hospital, 55 Commercial Rd, Melbourne 3004, Australia.; Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne 3004, Australia.; Monash Alfred Baker Centre for Cardiovascular Research, Monash University, Melbourne 3004, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne 3004, Australia., Wang B; Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne 3004, Australia.; Monash Alfred Baker Centre for Cardiovascular Research, Monash University, Melbourne 3004, Australia., Kaye DM; Department of Cardiology, Alfred Hospital, 55 Commercial Rd, Melbourne 3004, Australia.; Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne 3004, Australia.; Monash Alfred Baker Centre for Cardiovascular Research, Monash University, Melbourne 3004, Australia.; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne 3004, Australia.
Source: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2026 Jul 14; Vol. 12 (4), pp. 292-308.
Publication Type: Journal Article; Review
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2055-6845
DOI:10.1093/ehjcvp/pvag024